the alzheimer’s treatment controversy: implications of accelerated drug approvals
Published Streamed 2 years ago • 1.3K plays • Length 29:47Download video MP4
Download video MP3
Similar videos
-
4:21
phase ii trial of acu193 in alzheimer’s disease
-
16:45
fda final decision 2020 198
-
6:34
phase iia exploratory trial of t3d-959 in mild-moderate alzheimer’s disease
-
10:57
fda final decision 2020 199
-
3:03
the importance of the new covid-19 shot, and why sudafed may not work
-
13:45
how much emf radiation do teslas expose you to?
-
5:12
reporting on frontotemporal dementia
-
3:34
billionaire defends refusal to allow access to coastside beach
-
12:25
fda final decision 2020 180
-
4:44
recipes from the 'mind diet & plan cookbook'
-
6:54
fda final decision 2020 175
-
6:57:45
april 14, 2023 joint meeting of the pdac and the pcns
-
59:31
show 1318: challenging dogma about alzheimer disease and depression
-
2:56:05
biden faces growing doubt from democrats
-
1:42
170911 ch7 news - frontotemporal dementia trial world first
-
26:38
weekly webinar: infront-3 for ftd, and signal-ad for alzheimer’s disease-11/17/2022
-
5:51
frontotemporal dementia ed - section 3 - behavioral variant ftd
-
1:54
170911 atv10 news - frontotemporal dementia trial world first
-
1:10:21
che webinar: invisible hazards: state of the science on emf impacts and steps for policy change
-
4:25:07
defying dementia: charity livestream from the research lab
-
6:16
dan pearson testimonial final